Experience

• 

  Roots Pharmaceutical Company

  • Kuwait

  • Senior Product Specialist

    • Aug 2023 - Present
    • Kuwait

• 

  Galderma

  • Kuwait

  • Senior Medical Representative

    • May 2015 - Feb 2023
    • Kuwait

• 

  Johnson & Johnson

  • Kuwait

  • Account Manager

    • Jan 2011 - Apr 2015
    • Kuwait

    - Set annual BP, goals and objectives*Portfolio: Responsible of a total budget of 3.2 Million $ with the Following segments: a. Daily Disposable segment b. Reusable segment c. Astigmatism segment- Creating a steady growth in the market with Total growth of 20% in 2014 vs. 2013 with the following Key Achievements:1. Managing different types of customers with different criteria’s leading to detail the objectives according to their prospective.2. Opening a new sales opportunities through engaging new accounts in CL category business.3. Building strong relationships with the customers to establish a partnership condition to keep long term commitments and unlock new areas of business.4. Launching of two new products : a. 1 Day ACUVUE TrueEye at April 2011 b. 1 Day ACUVUE Moist for Astigmatism at April 20135. Through deep analysis and strong bonding, collaboration with the customers, created an opportunity to stock 1 Day ACUVUE moist for Astigmatism as first incidence in the Astigmatism segment.6. Grow ACUVUE market share by kicking the competition from several accounts.7. Creating a point of sale through building the practice fundamentals in the market to achieve long term goals.

• 

  SPIMACO

  • Kuwait

  • Medical representative

    • Jan 2010 - Dec 2010
    • Kuwait

    Key Acheivments :1. Reintroducing Klavox at YIACO Apollo Through the customers and establish a strong base of prescriptions.2. Open a new channels for Klavox at Al Saif Hospital to take a decision from Hospital Drug committee to enlist the product at their Pharmacy.

• 

  GSK

  • Egypt

  • Medical representative

    • Jun 2008 - Nov 2009
    • Egypt

    For the following CARDIVASCULAR Brands : Monopril, MonoZide, Capoten, Capozide and Lipostat